Earnings (Loss) Per Share (Tables)

6 Months Ended

Jun. 30, 2020

Schedule of Common Shares Used to Compute Delek's Basic and Diluted Earnings (Loss) Per Share

The following table sets forth the computation of basic and diluted earnings per share.



	Three Months Ended					Six Months Ended
	June 30,					June 30,
	2020		2019			2020			2019
Numerator:
Numerator for EPS
Income (loss) from continuing operations, net of tax	$	98.5	$	84.6		$	(208.5	)	$	239.0
Less: Income from continuing operations attributed to non-controlling interest	10.8		6.5			18.2			11.6
Numerator for basic and diluted EPS - attributable to Delek	$	87.7	$	78.1		$	(226.7	)	$	227.4

Numerator for EPS - discontinued operations
Loss from discontinued operations attributable to Delek	$	—	$	(0.8	)	$	—		$	(0.8	)

Denominator:
Weighted average common shares outstanding (denominator for basic EPS)	73,547,582		76,598,846			73,492,656			77,192,763
Dilutive effect of stock-based awards	480,461		681,846			—			690,522
Weighted average common shares outstanding, assuming dilution (denominator for diluted EPS)	74,028,043		77,280,692			73,492,656			77,883,285

EPS:
Basic income (loss) per share:
Income (loss) from continuing operations	$	1.19	$	1.02		$	(3.08	)	$	2.95
Loss from discontinued operations	$	—	(0.01		)	$	—		(0.01		)
Basic income (loss) per share	$	1.19	$	1.01		$	(3.08	)	$	2.94
Diluted income (loss) per share:
Income (loss) from continuing operations	$	1.18	$	1.01		$	(3.08	)	$	2.92
Loss from discontinued operations	$	—	(0.01		)	$	—		(0.01		)
Diluted income (loss) per share	$	1.18	$	1.00		$	(3.08	)	$	2.91

The following equity instruments were excluded from the diluted weighted average common shares outstanding because their effect would be antidilutive:
Antidilutive stock-based compensation (because average share price is less than exercise price)	3,922,290		1,927,150			3,328,789			2,153,411
Antidilutive due to loss	—		—			372,220			—
Total antidilutive stock-based compensation	3,922,290		1,927,150			3,701,009			2,153,411